Annibale B, Di Giulio E, Caruana P, Lahner E, Capurso G, Bordi C, Delle Fave G
Digestive and Liver Disease Unit, 2nd Medical School, University La Sapienza, Rome, Italy.
Aliment Pharmacol Ther. 2002 Oct;16(10):1723-31. doi: 10.1046/j.1365-2036.2002.01336.x.
Helicobacter pylori infection induces atrophic body gastritis, but the long-term effect of its cure on body atrophy is unclear.
To investigate the long-term effects of H. pylori cure on gastric morpho-functional parameters in patients with atrophic body gastritis.
Forty patients with atrophic body gastritis were cured of H. pylori infection. Gastroscopy with biopsies, gastrin and pepsinogen I levels and basal and stimulated acid secretion were evaluated before and 6-12 months after treatment.
At eradication assessment (6-12 months), in eight of the 40 patients, body atrophy was no longer observed, whereas in 32 of the 40 it remained substantially unchanged (2.03 +/- 0.12 vs. 1.83 +/- 0.15). In the eight patients with reversed body atrophy, gastrinaemia decreased significantly with respect to pre-treatment values (265 +/- 59.9 pg/mL vs. 51.8. +/- 6.04 pg/mL), and basal and stimulated acid secretion increased significantly after cure. In the 32 patients still presenting body atrophy, gastrinaemia was similar topre-treatment values (457 +/- 76.04 pg/mL vs. 335.1 +/- 58.8 pg/mL). At follow-up (21-25 and 32-70 months), the eight patients with reversed body atrophy continued with normal gastrinaemia (35.3 +/- 10.1 pg/mL vs. 38.5 +/- 8.8 pg/mL), but in the 19 patients with continued atrophy, both corporal atrophy and intestinal metaplasia remained substantially unchanged.
Following successful treatment in patients with atrophic body gastritis and H. pylori infection, long-term histological investigations are crucial in order to detect reversed body damage or to confirm continued body atrophy.
幽门螺杆菌感染可导致胃体萎缩性胃炎,但其根除治疗对胃体萎缩的长期影响尚不清楚。
研究幽门螺杆菌根除治疗对胃体萎缩性胃炎患者胃形态功能参数的长期影响。
40例胃体萎缩性胃炎患者的幽门螺杆菌感染得到根除。在治疗前及治疗后6 - 12个月评估胃镜检查及活检、胃泌素和胃蛋白酶原I水平以及基础和刺激胃酸分泌情况。
在根除评估时(6 - 12个月),40例患者中有8例胃体萎缩不再被观察到,而40例中的32例基本保持不变(2.03±0.12 vs. 1.83±0.15)。在8例胃体萎缩逆转的患者中,与治疗前相比,胃泌素血症显著降低(265±59.9 pg/mL vs. 51.8±6.04 pg/mL),根除治疗后基础和刺激胃酸分泌显著增加。在仍存在胃体萎缩的32例患者中,胃泌素血症与治疗前相似(457±76.04 pg/mL vs. 335.1±58.8 pg/mL)。在随访时(21 - 25个月和32 - 70个月),8例胃体萎缩逆转的患者胃泌素血症持续正常(35.3±10.1 pg/mL vs. 38.5±8.8 pg/mL),但在19例持续萎缩的患者中,胃体萎缩和肠化生均基本保持不变。
胃体萎缩性胃炎合并幽门螺杆菌感染的患者成功治疗后,长期组织学检查对于检测胃体损伤逆转或确认胃体萎缩持续存在至关重要。